|
1. Martinez AM, Sordia-Hernnndez LH, Morales JA, Merino M, Vidal O, García Garza MR, et al. A randomized clinical study assessing the effects of the antioxidants, resveratrol or SG1002, a hydrogen sulfide prodrug, on idiopathic oligoasthenozoospermia. Asia Pacific Journal of Reproduction. 2015 Jun; 4(2): 106-11. https://doi.org/10.1016/S2305-0500(15)30005-1 2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005 Apr; 352(16): 1685-95. doi: 10.1056/NEJMra043430 3. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999 Jan; 340(2): 115-26. doi: 10.1056/NEJM199901143400207 4. Black S, Kushner I, Samols D. C-reactive Protein. J Biol Chem. 2004 Nov; 279(47): 48487-90. doi: 10.1074/jbc.R400025200 5. Thompson D, Pepys MB, Wood SP. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure. 1999 Feb; 7(2): 169-77. doi: 10.1016/S0969-2126(99)80023-9 6. Lacina L, Brábek J, Král V, Kodet O, Smetana K Jr. Interleukin-6: a molecule with complex biological impact in cancer. Histol Histopathol. 2019 Feb; 34(2): 125-36. doi: 10.14670/HH-18-033 7. Gulhar R; Jialal I. Physiology, Acute Phase Reactants. Treasure Island (FL): StatPearls Publishing. 2019 Jan. 8. Olmos G, Lladó J. Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediators Inflamm. 2014; 2014: 861231. doi: 10.1155/2014/861231 9. Zordoky BN, Robertson IM, Dyck JR. Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochim Biophys Acta. 2015 Jun; 1852(6): 1155-77. doi: 10.1016/j.bbadis.2014.10.016 10. Fishbein MC, Fishbein GA. Arteriosclerosis: facts and fancy. Cardiovasc Pathol. 2015 Nov-Dec; 24(6): 335-42. doi: 10.1016/j.carpath.2015.07.007 11. Shi XZ, Lindholm PF, Sarna SK. NF-kappa B activation by oxidative stress and inflammation suppresses contractility in colonic circular smooth muscle cells. Gastroenterology. 2003 May; 124(5): 1369-80. 12. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet. 1993 Apr; 341(8852): 1103-4. doi: 10.1016/0140-6736(93)92472-6 13. Petrovski G, Gurusamy N, Das DK. Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci. 2011 Jan; 1215: 22-33. doi: 10.1111/j.1749-6632.2010.05843.x 14. Bellet RN, Adams L, Morris NR. The 6-minute walk test in outpatient cardiac rehabilitation: validity, reliability and responsiveness--a systematic review. Physiotherapy. 2012 Dec; 98(4): 277-86. doi: 10.1016/j.physio.2011.11.003 15. Brzycki M. Strength testing: predicting a one – rep max from repetitions-to-fatigue. J Phys Educ Recreat Dance. 1993; 64(1): 88-90. https://doi.org/10.1080/07303084.1993.10606684 16. Anderson L, Thompson DR, Oldridge N, Zwisler AD, Rees K, Martin N, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2016 Jan; (1): CD001800. doi: 10.1002/14651858.CD001800.pub3 17. Baltaci SB, Mogulkoc R, Baltaci AK. Resveratrol and exercise. Biomed Rep. 2016 Nov; 5(5): 525-30. doi: 10.3892/br.2016.777 18. Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. 2009 Jun; 14(2): 141-53. 19. West RR, Jones DA, Henderson AH. Rehabilitation after myocardial infarction trial (RAMIT): multi-centre randomised controlled trial of comprehensive cardiac rehabilitation in patients following acute myocardial infarction. Heart. 2012 Apr; 98(8): 637-44. doi: 10.1136/heartjnl-2011-300302 20. Peake J, Nosaka K, Suzuki K. Characterization of inflammatory responses to eccentric exercise in humans. Exerc Immunol Rev. 2005; 11: 64-85. 21. Liu X, Tian J, Bai Q, Ashraf MA, Sarfraz M, Zhao B. The effect and action mechanism of resveratrol on the vascular endothelial cell by high glucose treatment. Saudi J Biol Sci. 2016 Jan; 23(1): S16-21. doi: 10.1016/j.sjbs.2015.06.021 22. Kim EN, Kim MY, Lim JH, Kim Y, Shin SJ, Park CW, et al. The protective effect of resveratrol on vascular aging by modulation of the renin-angiotensin system. Atherosclerosis. 2018 Mar; 270: 123-31. doi: 10.1016/j.atherosclerosis.2018.01.043 23. Xie C. Resveratrol does not reduce CVD risk, prolong life - A statistical point of view. Contemp Clin Trials Commun. 2015 Oct; 1:1. doi: 10.1016/j.conctc.2015.08.004 24. Zhu Y, Feng B, He S, Su Z, Zheng G. Resveratrol combined with total flavones of hawthorn alleviate the endothelial cells injury after coronary bypass graft surgery. Phytomedicine. 2018 Feb; 40: 20-26. doi: 10.1016/j.phymed.2017.12.037 25. Gaeini AA , Satarifard S, Heidary A. Comparing the effect of eight weeks of high-intensity interval training and moderate-intensity continuous training on physiological variables of exercise stress test in cardiac patient after coronary artery bypass graft. J Isfahan Med Sch. 2014, 31(267): 2171-81. 26. Malekyian-Fini E, Kaviani-Nia A, Mahmoudi F. [The interactive effect of aerobic training and resveratrol supplementation on C-reactive protein and metabolic profiles in women with type 2 diabetes]. Feyz. 2015; 19(5): 372-81. [Article in Persian]
|
